BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 32199708)

  • 1. Efficacy of Furosemide, Oral Sodium Chloride, and Fluid Restriction for Treatment of Syndrome of Inappropriate Antidiuresis (SIAD): An Open-label Randomized Controlled Study (The EFFUSE-FLUID Trial).
    Krisanapan P; Vongsanim S; Pin-On P; Ruengorn C; Noppakun K
    Am J Kidney Dis; 2020 Aug; 76(2):203-212. PubMed ID: 32199708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluid Restriction Therapy for Chronic SIAD; Results of a Prospective Randomized Controlled Trial.
    Garrahy A; Galloway I; Hannon AM; Dineen R; O'Kelly P; Tormey WP; O'Reilly MW; Williams DJ; Sherlock M; Thompson CJ
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32879954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of nonresponse to fluid restriction in hyponatraemia due to the syndrome of inappropriate antidiuresis.
    Winzeler B; Lengsfeld S; Nigro N; Suter-Widmer I; Schütz P; Arici B; Bally M; Blum C; Bock A; Huber A; Müller B; Christ-Crain M
    J Intern Med; 2016 Dec; 280(6):609-617. PubMed ID: 27481546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Marked effect of furosemide and hypertonic saline in the treatment of SIAD after head injury].
    Iwasa H; Yamada T; Nakahara N; Shimabukuro H; Shinoda S; Indei I; Yamada N; Sato F; Saito T
    No Shinkei Geka; 1984 Apr; 12(5):651-5. PubMed ID: 6462361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of hyponatremic patients with nephrogenic syndrome of inappropriate antidiuresis: personal experience and review of published case reports.
    Vandergheynst F; Brachet C; Heinrichs C; Decaux G
    Nephron Clin Pract; 2012; 120(3):c168-72. PubMed ID: 22722264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intractable hyponatremia secondary to syndrome of inappropriate antidiuresis complicated with empty sella: A case report.
    Zheng W; Fan S; Chen J; Ma J
    Medicine (Baltimore); 2023 Apr; 102(14):e33436. PubMed ID: 37026946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIAD: practical recommendations for diagnosis and management.
    Cuesta M; Garrahy A; Thompson CJ
    J Endocrinol Invest; 2016 Sep; 39(9):991-1001. PubMed ID: 27094044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sudden hyponatremia with unconsciousness. Case report and brief overview of the syndrome of inadequate antidiuresis (SIAD or Schwartz-Bartter syndrome].
    Reimann D; Gross P
    Z Arztl Fortbild Qualitatssich; 1997 Sep; 91(6):533-6. PubMed ID: 9441028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis.
    Refardt J; Imber C; Sailer CO; Jeanloz N; Potasso L; Kutz A; Widmer A; Urwyler SA; Ebrahimi F; Vogt DR; Winzeler B; Christ-Crain M
    J Am Soc Nephrol; 2020 Mar; 31(3):615-624. PubMed ID: 32019783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyponatremia: pathophysiology, differential diagnosis and new aspects of treatment.
    Gross P; Wehrle R; Büssemaker E
    Clin Nephrol; 1996 Oct; 46(4):273-6. PubMed ID: 8905218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyponatremia and syndrome of inappropriate ADH secretion (SIADH)].
    Peri A; Parenti G; Giuliani A; Scrivano J; Pettorini L; Festuccia F; Pirozzi N; Mene' P
    G Ital Nefrol; 2012; 29(6):661-73. PubMed ID: 23229664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of failure to respond to fluid restriction in SIAD in clinical practice; time to re-evaluate clinical guidelines?
    Cuesta M; Ortolá A; Garrahy A; Calle Pascual AL; Runkle I; Thompson CJ
    QJM; 2017 Aug; 110(8):489-492. PubMed ID: 28186579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management.
    Warren AM; Grossmann M; Christ-Crain M; Russell N
    Endocr Rev; 2023 Sep; 44(5):819-861. PubMed ID: 36974717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion.
    Verbalis JG; Greenberg A; Burst V; Haymann JP; Johannsson G; Peri A; Poch E; Chiodo JA; Dave J
    Am J Med; 2016 May; 129(5):537.e9-537.e23. PubMed ID: 26584969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The syndrome of inappropriate antidiuresis].
    Frouget T
    Rev Med Interne; 2012 Oct; 33(10):556-66. PubMed ID: 22884285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndrome of Inappropriate Antidiuresis.
    Moritz ML
    Pediatr Clin North Am; 2019 Feb; 66(1):209-226. PubMed ID: 30454744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study.
    Tominaga N; Kida K; Inomata T; Sato N; Izumi T; Akashi YJ; Shibagaki Y
    Am J Nephrol; 2017; 46(5):417-426. PubMed ID: 29130954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of protein supplementation on plasma sodium levels in the syndrome of inappropriate antidiuresis: a monocentric, open-label, proof-of-concept study-the TREASURE study.
    Monnerat S; Atila C; Baur F; Santos de Jesus J; Refardt J; Dickenmann M; Christ-Crain M
    Eur J Endocrinol; 2023 Aug; 189(2):252-261. PubMed ID: 37540987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD.
    Arecco A; Demontis D; Della Sala L; Musso N; Gay S; Boschetti M; Ferone D; Gatto F
    Front Endocrinol (Lausanne); 2023; 14():1309657. PubMed ID: 38288467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan.
    Ohara K; Masuda T; Murakami T; Imai T; Yoshizawa H; Nakagawa S; Okada M; Miki A; Myoga A; Sugase T; Sekiguchi C; Miyazawa Y; Maeshima A; Akimoto T; Saito O; Muto S; Nagata D
    Nephrology (Carlton); 2019 Sep; 24(9):904-911. PubMed ID: 30578654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.